KPC type beta-lactamase, rural Pennsylvania.
作者信息
Pope Jonathan, Adams Jennifer, Doi Yohei, Szabo Dora, Paterson David L
出版信息
Emerg Infect Dis. 2006 Oct;12(10):1613-4. doi: 10.3201/eid1210.060297.
Abstract
摘要
相似文献
1
KPC type beta-lactamase, rural Pennsylvania.
Emerg Infect Dis. 2006 Oct;12(10):1613-4. doi: 10.3201/eid1210.060297.
2
Emergence of KPC-producing Klebsiella pneumoniae in Texas.
Diagn Microbiol Infect Dis. 2011 Feb;69(2):234-5. doi: 10.1016/j.diagmicrobio.2010.09.003.
3
Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in a Klebsiella pneumoniae isolate from Switzerland.
J Antimicrob Chemother. 2011 Mar;66(3):675-6. doi: 10.1093/jac/dkq499. Epub 2010 Dec 29.
4
A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy.
New Microbiol. 2010 Jul;33(3):281-2.
5
Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan.
J Antimicrob Chemother. 2011 May;66(5):1182-4. doi: 10.1093/jac/dkr025. Epub 2011 Feb 8.
6
Nosocomial liver abscess caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
J Clin Microbiol. 2007 Jan;45(1):266-9. doi: 10.1128/JCM.01413-06. Epub 2006 Nov 8.
7
[Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
Zhonghua Yi Xue Za Zhi. 2004 Nov 17;84(22):1918-20.
8
Clonal spread of Klebsiella pneumoniae producing CMY-2 AmpC-type beta-lactamase in surgical intensive care units.
J Microbiol Immunol Infect. 2009 Dec;42(6):479-87.
9
KPC-2-producing Klebsiella pneumoniae in Brazil: a widespread threat in waiting?
Int J Infect Dis. 2010 Jun;14(6):e539-40. doi: 10.1016/j.ijid.2009.07.004. Epub 2009 Nov 4.
10
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Antimicrob Agents Chemother. 2007 Aug;51(8):3026-9. doi: 10.1128/AAC.00299-07. Epub 2007 Jun 11.
引用本文的文献
1
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.
Lancet Infect Dis. 2013 Sep;13(9):785-96. doi: 10.1016/S1473-3099(13)70190-7.
2
Nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Klebsiella oxytoca in Austria.
Antimicrob Agents Chemother. 2012 Apr;56(4):2158-61. doi: 10.1128/AAC.05440-11. Epub 2012 Jan 30.
3
Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Infect Control Hosp Epidemiol. 2009 Dec;30(12):1180-5. doi: 10.1086/648451.
4
Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China.
Antimicrob Agents Chemother. 2009 Oct;53(10):4333-8. doi: 10.1128/AAC.00260-09. Epub 2009 Jul 20.
5
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.
J Antimicrob Chemother. 2009 Mar;63(3):427-37. doi: 10.1093/jac/dkn547. Epub 2009 Jan 20.
6
Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.
J Clin Microbiol. 2008 Jun;46(6):2066-9. doi: 10.1128/JCM.02038-07. Epub 2008 Apr 2.
7
Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases.
Biochemistry. 2007 May 15;46(19):5732-40. doi: 10.1021/bi700300u. Epub 2007 Apr 19.
本文引用的文献
1
Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.
Antimicrob Agents Chemother. 2005 Jul;49(7):3018-20. doi: 10.1128/AAC.49.7.3018-3020.2005.
2
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci in rural communities, western United States.
Emerg Infect Dis. 2005 Jun;11(6):895-903. doi: 10.3201/eid1106.050156.
3
Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.
Antimicrob Agents Chemother. 2004 Dec;48(12):4793-9. doi: 10.1128/AAC.48.12.4793-4799.2004.
4
Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes.
Clin Infect Dis. 2004 Jun 15;38(12):1736-41. doi: 10.1086/421094. Epub 2004 May 25.
5
Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.
J Clin Microbiol. 2004 Mar;42(3):1089-94. doi: 10.1128/JCM.42.3.1089-1094.2004.
6
Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases.
Antimicrob Agents Chemother. 2003 Nov;47(11):3554-60. doi: 10.1128/AAC.47.11.3554-3560.2003.
7
Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards.
Diagn Microbiol Infect Dis. 2003 Sep;47(1):303-11. doi: 10.1016/s0732-8893(03)00092-0.
8
Control of an outbreak of infection due to extended-spectrum beta-lactamase--producing Escherichia coli in a liver transplantation unit.
Clin Infect Dis. 2001 Jul 1;33(1):126-8. doi: 10.1086/320882. Epub 2001 May 23.
9
Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
Antimicrob Agents Chemother. 2001 Apr;45(4):1151-61. doi: 10.1128/AAC.45.4.1151-1161.2001.
Zotero 插件